AI governance is fast becoming a fiduciary obligation, not a project

Three years ago, “AI strategy” was a discretionary item on the digital agenda – useful, ambitious, optional. Today, for private wealth firms and family offices in the UK, it is closer to a fiduciary obligation. The change is quiet but consequential.

The shift in regulatory posture

Consumer Duty has already pushed firms to evidence outcomes rather than merely describe processes. The forthcoming CCI regime extends that into AI-specific accountability. The ICO has tightened expectations around automated decision-making, model documentation, and bias controls. The EU AI Act’s extraterritorial scope catches UK firms with EU clients in ways that often surprise legal teams.

Against that backdrop, “we have an AI committee” is no longer a satisfactory board answer. The board needs to be able to answer: what AI is in use, by whom, with what controls, against what risk appetite, and reviewed how often?

What changes for the board

Three things, in our experience:

• The minimum standard for board papers has risen. An AI proposal now needs governance scaffolding alongside the commercial case – model inventory, risk classification, oversight plan.
• Independent review is moving from optional to expected. Boards that previously challenged executive proposals informally are increasingly commissioning independent assessment, particularly where the executive sponsor is the same person commercially incentivised by the outcome.
• Documentation is the deliverable. Verbal assurance does not survive a regulatory enquiry. Written records of the board’s consideration, the alternatives weighed, and the controls accepted are the actual artefact.

What good looks like

An AI Readiness Audit produces three things that materially help: a scored maturity baseline (so progress can be evidenced), a governance policy aligned to ICO and FCA frameworks, and a sequenced roadmap that maps decisions to a reviewable timetable. None of these are bureaucratic for their own sake – they are the substrate of evidenced fiduciary care.

The firms that move first will not be the ones with the most ambitious AI roadmaps. They will be the ones whose governance can keep pace with their ambition.